Assembly Biosciences



Alumni, Venture-Backed
Assembly Biosciences

Assembly Biosciences, Inc. is a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral biotherapeutics for disorders associated with the microbiome.